StonvexLoading…
StonvexStonvexStonvexCore line items from GENB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q1 2025 2025-03-31 |
|---|---|---|
Revenue | $7.22M | $8.82M |
Operating Income | $-64.11M | $-48.15M |
Net Income | $-61.45M | $-41.69M |
EPS (Diluted) | $-1.07 | $-1.62 |
Total Assets | $625.74M | Not available |
Total Liabilities | $110.94M | Not available |
Cash & Equivalents | $160.57M | $220.61M |
Free Cash Flow OCF − CapEx | $-84.17M | $-53.93M |
Shares Outstanding | 128.19M | 32.79M |